Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Xueshuantong Capsule in Early Recovery Ischemic Stroke
CTR20170885Phase 2Active
- Sponsor
- Zhongsheng Pharma
- Start
- Aug 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fufang Xueshuantong in ischemic stroke, sponsored by Zhongsheng Pharma. Started Aug 2017; status: active.
02
Drugs
Fufang Xueshuantong
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20170885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170885.